Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

34 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Molecular signature associated with cladribine treatment in patients with multiple sclerosis.
Fissolo N, Calvo-Barreiro L, Eixarch H, Boschert U, Villar LM, Costa-Frossard L, Ferrer M, Sanchez A, Borràs E, Sabidó E, Espejo C, Montalban X, Comabella M. Fissolo N, et al. Among authors: eixarch h. Front Immunol. 2023 Jul 25;14:1233546. doi: 10.3389/fimmu.2023.1233546. eCollection 2023. Front Immunol. 2023. PMID: 37559720 Free PMC article.
Immunomodulatory Effects Associated with Cladribine Treatment.
Fissolo N, Calvo-Barreiro L, Eixarch H, Boschert U, Espejo C, Montalban X, Comabella M. Fissolo N, et al. Among authors: eixarch h. Cells. 2021 Dec 10;10(12):3488. doi: 10.3390/cells10123488. Cells. 2021. PMID: 34943995 Free PMC article.
Regulatory lymphocytes are key factors in MHC-independent resistance to EAE.
Marín N, Mecha M, Espejo C, Mestre L, Eixarch H, Montalban X, Álvarez-Cermeño JC, Guaza C, Villar LM. Marín N, et al. Among authors: eixarch h. J Immunol Res. 2014;2014:156380. doi: 10.1155/2014/156380. Epub 2014 Apr 27. J Immunol Res. 2014. PMID: 24868560 Free PMC article.
Semaphorin 7A as a Potential Therapeutic Target for Multiple Sclerosis.
Gutiérrez-Franco A, Eixarch H, Costa C, Gil V, Castillo M, Calvo-Barreiro L, Montalban X, Del Río JA, Espejo C. Gutiérrez-Franco A, et al. Among authors: eixarch h. Mol Neurobiol. 2017 Aug;54(6):4820-4831. doi: 10.1007/s12035-016-0154-2. Epub 2016 Oct 6. Mol Neurobiol. 2017. PMID: 27714632
Expression of Bone Morphogenetic Proteins in Multiple Sclerosis Lesions.
Costa C, Eixarch H, Martínez-Sáez E, Calvo-Barreiro L, Calucho M, Castro Z, Ortega-Aznar A, Ramón Y Cajal S, Montalban X, Espejo C. Costa C, et al. Among authors: eixarch h. Am J Pathol. 2019 Mar;189(3):665-676. doi: 10.1016/j.ajpath.2018.11.007. Epub 2018 Dec 13. Am J Pathol. 2019. PMID: 30553833 Free article.
A New Risk Variant for Multiple Sclerosis at 11q23.3 Locus Is Associated with Expansion of CXCR5+ Circulating Regulatory T Cells.
Gil-Varea E, Fedetz M, Eixarch H, Spataro N, Villar LM, Urcelay E, Saiz A, Fernández Ó, Leyva L, Ramió-Torrentà L, Vandenbroeck K, Otaegui D, Castillo-Triviño T, Izquierdo G, Malhotra S, Bosch E, Navarro A, Alcina A, Montalban X, Matesanz F, Comabella M. Gil-Varea E, et al. Among authors: eixarch h. J Clin Med. 2020 Feb 26;9(3):625. doi: 10.3390/jcm9030625. J Clin Med. 2020. PMID: 32110891 Free PMC article.
NLRP3 inflammasome as prognostic factor and therapeutic target in primary progressive multiple sclerosis patients.
Malhotra S, Costa C, Eixarch H, Keller CW, Amman L, Martínez-Banaclocha H, Midaglia L, Sarró E, Machín-Díaz I, Villar LM, Triviño JC, Oliver-Martos B, Parladé LN, Calvo-Barreiro L, Matesanz F, Vandenbroeck K, Urcelay E, Martínez-Ginés ML, Tejeda-Velarde A, Fissolo N, Castilló J, Sanchez A, Robertson AAB, Clemente D, Prinz M, Pelegrin P, Lünemann JD, Espejo C, Montalban X, Comabella M. Malhotra S, et al. Among authors: eixarch h. Brain. 2020 May 1;143(5):1414-1430. doi: 10.1093/brain/awaa084. Brain. 2020. PMID: 32282893 Free article.
34 results